Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis

NCT00885547 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

90

Enrollment

OTHER

Sponsor class

Stopped low-rate of enrollment

Conditions

IgA Nephropathy

Interventions

DRUG: tripterygium wilfordii (TW)

Sponsor

Nanjing University School of Medicine